Translate Bio, Inc. Gains 46.98%

Tue, Jun 23, 2020 at 05:30 PM

Translate Bio, Inc. (TBIO:NASDAQ) jumped higher at $23.87, representing a gain of 47%. On Mon 22 Jun 20, TBIO:NASDAQ hit a New 2-Week High of $16.24. The stock got featured on our News Catalysts scanner on Tue 23 Jun 20 at 04:56 PM in the 'BIOTECH' category. From Mon 08 Jun 20, the stock recorded 60.00% Up Days and 54.55% Green Days

The stock spiked on Tue 19 May 20 at $21.95 with a volume of 1M+, and its share price has been moving sideways in recent weeks.

About Translate Bio, Inc. (TBIO:NASDAQ)

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Top 10 Gainers:

Barnwell Industries, Inc. (BRN:NYSEMKT), 73.19%
Lilis Energy, Inc. (LLEX:NYSEMKT), 63.91%
Translate Bio, Inc. (TBIO:NASDAQ), 46.98%
Inovio Pharmaceuticals, Inc. (INO:NASDAQ), 40.98%
China Rapid Finance Limited (XRF:NYSE), 40.89%
Seanergy Maritime Holdings Corp. (SHIP:NASDAQ), 40.07%
Fuwei Films (Holdings) Co., Ltd. (FFHL:NASDAQ), 39.87%
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 36.78%
Urban One, Inc. (UONE:NASDAQ), 34.14%
Infrastructure and Energy Alternatives, Inc. (IEA:NASDAQ), 25.78%